Bioelectronics Corp (BIEL)

[gimmee greenbacks]

Great point Probity!

“Some company might. My understanding is that when a company’s FDA - cleared product patent expires, another entity cannot use the existing clearance(s) by simply replicating the product. They must submit a new application(s) for FDA clearance that complies with current regulations and guidelines.”



BIEL